ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Surgical Experience and Treatment Options for Hepatic Cystic Disease

M. Crowley1, K. Robichaux2, A. Kumar1, J. Buggs3, J. Sokolich4

1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of South Florida, Tampa, FL, 3Transplant Surgery, Tampa General Hospital, Tampa, FL, 4Hepatobiliary Surgery, Valley Presbyterian Hospital, San Fernando Valley, CA

Meeting: 2021 American Transplant Congress

Abstract number: 1124

Keywords: Liver preservation, Liver transplantation

Topic: Clinical Science » Liver » Liver: Hepatobiliary Surgery

Session Information

Session Name: Liver: Hepatobiliary Surgery

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Benign hepatic cysts may require surgical removal when symptomatic particularly in the setting of genetic disorders such as autosomal dominant polycystic kidney disease (ADPKD) or autosomal dominant polycystic liver disease (PCLD) which may also be called isolated PLD. Operations for symptomatic hepatic cysts can include liver transplantation. The purpose of this study was to compare outcomes in patients with hepatic cysts treated with liver transplantation and or fenestration.

*Methods: A retrospective chart review was conducted which included all patients treated surgically for hepatic cystic disease at a single center from June 2011 to May 2020. Treatment groups were divided into those that received fenestrations versus liver transplants. Data were obtained from electronic health records and analyzed with IBM-SPSS version 26. Statistical significance was set at a p-value of less than 5%.

*Results: A total of 35 patients were included, 26 underwent fenestration, and 9 had liver transplantation. There were no significant differences in sex, race, age, or BMI between the fenestration and transplant groups. Creatinine and MELD scores were significantly higher in the transplant arm (p<.039, .021 respectively). All transplant patients had ADPKD and greater than 5 cysts removed. Only half the fenestration group had ADPKD, and 27% had greater than 5 cysts removed. The 30-day complication rate was higher in the transplant group (33%) vs. fenestration (4%). The complications included bile leaks, respiratory distress, and exploratory laparotomy. Five (19%) fenestrations required more than one operation and only one (4%) of the 5 patients had ADPKD.

*Conclusions: Cyst fenestration and liver transplants may be used to treat symptomatic liver cysts. Liver transplantation is typically reserved for patients with genetic disorders such as ADPKD and isolated PLD, which are associated with a large number of cysts. Patients with ADPKD, even those that require kidney transplants make excellent candidates for fenestration when applicable.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Crowley M, Robichaux K, Kumar A, Buggs J, Sokolich J. The Surgical Experience and Treatment Options for Hepatic Cystic Disease [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/the-surgical-experience-and-treatment-options-for-hepatic-cystic-disease/. Accessed June 2, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences